Eritrea vs Hong Kong, China: HIV-positive TB patients on ART (antiretroviral therapy)
Eritrea
100.0%
in 2024
Hong Kong, China
100.0%
in 2024
Eritrea rank
1st
Hong Kong, China rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Eritrea
- Hong Kong, China
How they compare
Eritrea currently reports 100.0% against 100.0% in Hong Kong, China, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Eritrea ahead.
Eritrea ranks 1st and Hong Kong, China ranks 1st of 144 countries.
Eritrea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eritrea | Hong Kong, China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95.4% | 31.5% | 63.9% | Eritrea |
| 2020s | 98.2% | 92.2% | 6.0% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Eritrea or Hong Kong, China?
- Eritrea, at 100.0% against 100.0% in Hong Kong, China as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Eritrea and Hong Kong, China?
- 0.0%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Hong Kong, China?
- 10 years are reported by both, from 2015 to 2024.
- How do Eritrea and Hong Kong, China rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Eritrea ranks 1st and Hong Kong, China ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.